Author:
Pesa Jacqueline A.,Muser Erik,Montejano Leslie B.,Smith David M.,Meyers Oren I.
Funder
Janssen Scientific Affairs, LLC.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. McGuire TG. Measuring the economic costs of schizophrenia. Schizophr Bull. 1991;17(3):375–88.
2. Young AS, Sullivan G, Burnam MA, Brook RH. Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry. 1998;55:611–7.
3. Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry. 2005;66(9):1122–9.
4. Desai PR, Lawson KA, Barner JC, Rascati KL. Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients. J Manag Care Pharm. 2013;19(6):468–77.
5. O’Malley AJ, Frank RG, Normand S-LT. Estimating cost-offsets of new medications: use of new antipsychotics and mental health costs for schizophrenia. Stat Med. 2011;30(16):1971–88.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献